Quest Diagnostics Incorporated
DGX
$173.76
-$2.11-1.20%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 10.16B | 9.87B | 9.54B | 9.35B | 9.29B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 10.16B | 9.87B | 9.54B | 9.35B | 9.29B |
| Cost of Revenue | 6.80B | 6.60B | 6.39B | 6.26B | 6.22B |
| Gross Profit | 3.36B | 3.27B | 3.15B | 3.09B | 3.07B |
| SG&A Expenses | 1.76B | 1.73B | 1.68B | 1.62B | 1.62B |
| Depreciation & Amortization | 137.00M | 127.00M | 117.00M | 112.00M | 111.00M |
| Other Operating Expenses | 1.00M | 1.00M | -2.00M | 0.00 | -1.00M |
| Total Operating Expenses | 8.70B | 8.46B | 8.19B | 7.99B | 7.95B |
| Operating Income | 1.46B | 1.41B | 1.35B | 1.35B | 1.34B |
| Income Before Tax | 1.21B | 1.19B | 1.14B | 1.14B | 1.15B |
| Income Tax Expenses | 266.00M | 273.00M | 245.00M | 248.00M | 249.00M |
| Earnings from Continuing Operations | 948.00 | 921.00 | 890.00 | 890.00 | 899.00 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -51.00M | -50.00M | -49.00M | -50.00M | -53.00M |
| Net Income | 897.00M | 871.00M | 841.00M | 840.00M | 846.00M |
| EBIT | 1.46B | 1.41B | 1.35B | 1.35B | 1.34B |
| EBITDA | 1.98B | 1.91B | 1.82B | 1.81B | 1.79B |
| EPS Basic | 8.02 | 7.78 | 7.52 | 7.50 | 7.53 |
| Normalized Basic EPS | 6.77 | 6.66 | 6.46 | 6.49 | 6.48 |
| EPS Diluted | 7.94 | 7.72 | 7.39 | 7.36 | 7.38 |
| Normalized Diluted EPS | 6.68 | 6.58 | 6.40 | 6.42 | 6.40 |
| Average Basic Shares Outstanding | 445.00M | 445.00M | 446.00M | 446.00M | 447.00M |
| Average Diluted Shares Outstanding | 451.00M | 450.00M | 450.00M | 451.00M | 453.00M |
| Dividend Per Share | 3.05 | 3.00 | 2.96 | 2.92 | 2.88 |
| Payout Ratio | 37.46% | 38.00% | 38.88% | 38.45% | 37.71% |